SENSEX NIFTY

Glenmark Pharmaceuticals

Aug 01, 2014 at 11:25 | Source: CNBC-TV18
Deven Choksey, MD of KR Choksey Shares & Securities is of the view that one may add Glenmark Pharma and Cipla into the portfolio.
Aug 01, 2014 at 09:19 | Source: CNBC-TV18
Deven Choksey MD, KR Choksey Shares & Securities does not expect further damage to Indian market. In fact he thinks loss of Russia could be gain for India and market could see higher allocation in the near-term.
Jul 31, 2014 at 15:56 | Source: Moneycontrol.com
Brokerage house Emkay Global Financial Services is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 728 in its July 25, 2014 research report.
Jul 31, 2014 at 11:25 | Source: CNBC-TV18
"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said.
Jul 30, 2014 at 16:02 | Source: Moneycontrol.com
Sharekhan has recommended hold rating on Glenmark Pharma with a target price of Rs 670, in its research report dated July 25, 2014.
Jul 28, 2014 at 18:34 | Source: Moneycontrol.com
Religare Capital is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 725 in its July 25, 2014 research report.
Jul 28, 2014 at 15:46 | Source: Moneycontrol.com
Dolat Capital is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 688 in its July 25, 2014 research report.
Jul 28, 2014 at 15:43 | Source: Moneycontrol.com
ICICIdirect.com has recommended a hold rating on Glenmark Pharma with a target price of Rs 644 per share in its July 26, 2014 research report.
Jul 25, 2014 at 22:11 | Source: Moneycontrol.com
Glenmark Pharmaceuticals has informed that the Annual General Meeting (AGM) of the Company was held on July 25, 2014.
Jul 25, 2014 at 14:49 | Source: Moneycontrol.com
Macquarie maintains outperform with a target of Rs 835 per share. The brokerage expects emerging markets strong growth momentum to continue and is hoping the US markets to pick up in second half, which was subdued due to lack of approvals in Q1FY15.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

3639 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th

BSE/NSE Announcer

Platinum Member

3639 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th

BSE/NSE Announcer

Platinum Member

3639 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th

BSE/NSE Announcer

Platinum Member

3639 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd

BSE/NSE Announcer

Platinum Member

3639 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th

adviserbola

Platinum Member

212 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th

Amrita Gaba

New Member

345 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th

BSE/NSE Announcer

Platinum Member

3639 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th

News across the web »
Jul 24, 2014 at 22:00 | Source: NDTV Profit
Jul 15, 2014 at 20:00 | Source: VC Circle
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.